Last reviewed · How we verify

Definity infusion — Competitive Intelligence Brief

Definity infusion (Definity infusion) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Ultrasound contrast agent. Area: Cardiology / Diagnostic Imaging.

marketed Ultrasound contrast agent Cardiology / Diagnostic Imaging Small molecule Live · refreshed every 30 min

Target snapshot

Definity infusion (Definity infusion) — Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. Definity is an ultrasound contrast agent composed of perflutren-filled microbubbles that enhance echocardiographic imaging by increasing ultrasound backscatter from the left ventricular cavity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Definity infusion TARGET Definity infusion Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University marketed Ultrasound contrast agent
Optison echocardiography contrast agent Optison echocardiography contrast agent University of Utah marketed Ultrasound contrast agent
Contrast-Enhanced Ultrasound using Lumason Contrast-Enhanced Ultrasound using Lumason Children's Hospital of Philadelphia marketed Ultrasound contrast agent
Perflutren lipid Perflutren lipid UNC Lineberger Comprehensive Cancer Center marketed Ultrasound contrast agent
Sonovue and Sonazoid Sonovue and Sonazoid Second Affiliated Hospital, School of Medicine, Zhejiang University phase 3 Ultrasound contrast agent
SonoVue-enhanced ultrasound SonoVue-enhanced ultrasound Bracco Diagnostics, Inc phase 3 Ultrasound contrast agent
SonoVue® SonoVue® GE Healthcare phase 3 Ultrasound contrast agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Ultrasound contrast agent class)

  1. Second Affiliated Hospital, School of Medicine, Zhejiang University · 2 drugs in this class
  2. Bracco Diagnostics, Inc · 1 drug in this class
  3. Centre Hospitalier Régional Metz-Thionville · 1 drug in this class
  4. Children's Hospital of Philadelphia · 1 drug in this class
  5. GE Healthcare · 1 drug in this class
  6. Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · 1 drug in this class
  7. Sunnybrook Health Sciences Centre · 1 drug in this class
  8. UNC Lineberger Comprehensive Cancer Center · 1 drug in this class
  9. University of Utah · 1 drug in this class
  10. Acusphere · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Definity infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/definity-infusion. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: